I agree. If the TO benchmark U308 price is $9.80-$9.90 set by recent TO offers there must be more than a couple of companies, including Korean and Russian, that would see that CGNPC's offer is optimistic at sub $5 and will counter offer. There are always players looking for cheap assets.
HUSAB is the premium Uranium play and hopefully somewhere near true value is the final outcome. Maybe KAH are hanging in for more than the widely speculated 2.70 based on these recent valuations and the increased recourse.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.65M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $4.687K | 524.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 441211 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 4762564 | 2 |
View Market Depth
| Last trade - 14.11pm 24/06/2025 (20 minute delay) ? |
| EXT (ASX) Chart |